|
|
|
|
|
|
|
|
Conclusions
Combination therapy is administered more often than carboplatin; especially in those with younger age, better PS and nonmucinous histology. Recurrence and death rates were similar with both treatments. Well-designed trials are needed to identify the optimum chemotherapy regimen in this group.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.